Northwest & Ethical Investments’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-49,075
Closed -$2.92M 390
2019
Q4
$2.92M Sell
49,075
-6,994
-12% -$376K 0.13% 205
2019
Q3
$2.98M Sell
56,069
-13,772
-20% -$707K 0.15% 189
2019
Q2
$3.57M Buy
69,841
+7,309
+12% +$340K 0.18% 160
2019
Q1
$3.24M Buy
62,532
+12,110
+24% +$587K 0.17% 173
2018
Q4
$1.98M Buy
+50,422
New +$2.34M 0.12% 231

Other funds holding SYNH

Northwest & Ethical Investments's SYNH Position: Q1 2020 in Review

Northwest & Ethical Investments sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2020, closing a stake of 49,075 shares — an estimated $2.92M sold.

Northwest & Ethical Investments first reported a position in SYNH in Q4 2018 and held it in 5 quarters. The position peaked at $3.57M in Q2 2019. 260 funds tracked by Wall St. Rank hold SYNH as of Q1 2020.

  • Northwest & Ethical Investments reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2020 after selling out during the quarter.
  • Northwest & Ethical Investments sold 49,075 Syneos Health, Inc. Class A Common Stock shares in Q1 2020, an estimated $2.92M.
  • Northwest & Ethical Investments first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2018 and held it in 5 quarters.
  • Northwest & Ethical Investments's Syneos Health, Inc. Class A Common Stock position peaked at $3.57M in Q2 2019.
  • 260 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2020.

Based on Northwest & Ethical Investments's 13F filing for Q1 2020, filed 8 Jul 2025.